Thyroid hormone replacement: an iatrogenic problem.

Area of Science:

• Endocrinology
• Pharmacology
• Internal Medicine

Background:

• Thyroid hormone replacement therapy, a 19th-century medical innovation, remains a cornerstone treatment.
• Despite its success, current methods for assessing thyroxine replacement adequacy are contentious.
• The adoption of serum thyrotropin (TSH) in the 1970s as the primary indicator is debated.

Purpose of the Study:

• To evaluate the effectiveness of serum TSH concentration in assessing thyroxine replacement.
• To explore alternative methods for monitoring thyroid hormone therapy.
• To address patient concerns regarding current thyroid hormone replacement protocols.

Main Methods:

• Review of published literature on thyroid hormone replacement therapy.
• Analysis of the correlation between serum TSH levels and clinical status in patients on thyroxine.
• Consideration of serum T3 measurements as a potential diagnostic tool.

Main Results:

• The serum TSH concentration is frequently a poor indicator of a patient's clinical status during thyroxine replacement.
• Clinical assessment remains a crucial component in evaluating treatment adequacy.
• Serum T3 measurement may be necessary in specific cases to detect over-replacement.

Conclusions:

• Relying solely on serum TSH for assessing thyroxine replacement is inadequate.
• Clinical evaluation should be prioritized, supplemented by serum T3 measurements when necessary.
• Revisiting current practices in thyroid hormone replacement monitoring is warranted.